Overview Fundamentals API Earnings EOD API Sample Code Pricing

Ascelia Pharma AB (publ) (ACE ST) stock market data APIs

kr2.8 0.19(7.3%) as of November 21, 2024
Price chart is built with Anychart

Ascelia Pharma AB (publ), a biotech company, focuses on orphan oncology treatments in Sweden. The company identifies, develops, and commercializes novel drugs to address unmet needs for rare cancer conditions. It develops Orviglance, a novel non-gadolinium diagnostic drug, which is in Phase 3 trial for use in MRI-scans of the liver; and Oncoral, a novel oral irinotecan chemotherapy tablet, that is in Phase 2 trial for the treatment of gastric cancer. Ascelia Pharma AB (publ) was incorporated in 1999 and is based in Malmö, Sweden.

Ascelia Pharma AB (publ) Financial Data Overview

2.855
2.8
-
2.495
2.98
1.8886-17.98
261 M
96 080 K
0
-0.42
1.031
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ACE',
Type: 'Common Stock',
Name: 'Ascelia Pharma AB (publ)',
Exchange: 'ST',
CurrencyCode: 'SEK',
CurrencyName: 'Swedish krone',
CurrencySymbol: 'kr',
CountryName: 'Sweden',
CountryISO: 'SE',
OpenFigi: NULL,
ISIN: 'SE0010573113',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Ascelia Pharma AB (publ) Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -57 377 000
  • Earnings Per Share -0.61
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Ascelia Pharma AB (publ) Earnings via APIs

  • Latest Release 2024-11-07
  • EPS/Forecast -0.2

Get Ascelia Pharma AB (publ) End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com